XXII 22nd Century Group, Inc.

Nasdaq xxiicentury.com


$ 1.56 $ 0.00 (0 %)    

Thursday, 16-Oct-2025 07:45:46 EDT
QQQ $ 604.95 $ 0.00 (0 %)
DIA $ 463.54 $ 0.00 (0 %)
SPY $ 667.15 $ 0.00 (0 %)
TLT $ 91.04 $ 0.00 (0 %)
GLD $ 389.98 $ 0.00 (0 %)
$ 1.55
$ 1.58
$ 1.55 x 12
$ 1.57 x 20
-- - --
$ 1.46 - $ 434.70
177,695
na
5.69M
$ 1.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-20-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-06-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-09-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 03-11-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 03-11-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 03-06-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 05-03-2018 03-31-2018 10-Q
31 03-07-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-08-2017 03-31-2017 10-Q
35 03-08-2017 12-31-2016 10-K
36 11-08-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 02-18-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 22nd-century-group-supports-fda-nicotine-standard-projected-to-avert-43m-deaths-600b-in-annual-harm-vlnc-products-could-replace-conventional-tobacco-within-two-years

- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the...

Core News & Articles

Gainers Amaze Holdings (AMEX:AMZE) shares rose 15.8% to $3.6 during Thursday's after-market session. The market value of t...

 why-pepgen-shares-are-trading-higher-by-112-here-are-20-stocks-moving-premarket

Shares of PepGen Inc. (NASDAQ: PEPG) rose sharply in pre-market trading after the company announced the launch of an underwritt...

 22nd-century-stock-jumps-39-pre-market-on-95-million-insurance-settlement

Shares of 22nd Century Group Inc. (NASDAQ: XXII) jumped 39.07% in pre-market trading, reaching $2.10, after the company reveale...

 22nd-century-group-announced-that-it-has-reached-an-agreement-to-settle-all-claims-for-business-interruption-related-to-the-grass-valley-incident-that-occurred-in-november-2022-for-a-one-time-payment-of-95m-in-cash-from-its-insurers

Non-dilutive Cash Puts Growth Capital and Runway to Breakeven on the Balance SheetCompany is Positioned to Drive to Profitabili...

 22nd-century-group-shares-are-trading-higher-friday-whats-going-on

22nd Century Group shares are trading higher Friday after the company announced it repaid the remaining $3.9 million of its sen...

Core News & Articles

FDX: 8% | FedEx shares are trading higher after the company reported better-than-expected Q1 EPS and sales. SCHL: -12% | Schola...

 22nd-centurys-pinnacle-vln-cigarettes-gain-second-early-adopter-set-for-september-launch-at-nearly-1000-us-c-store-locations-announces-the-first-shipments-of-its-pinnacle-vln-products-into-distribution

Pinnacle VLN® from 22nd Century Gains 2nd Early Adopter to Join Popular Pinnacle Branded Conventional Cigarette Products Alread...

 22nd-century-group-highlights-vln-as-only-fda-authorized-reduced-nicotine-cigarette-compliant-with-proposed-federal-standard

22nd Century VLN® products are the only combustible cigarettes authorized by the FDA as a reduced nicotine content product that...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION